AI Vendor Consolidation + Revenue Cycle

Hospitals Are Trimming AI Vendors in 2026 — Why Platform Beats Point Solutions for Revenue Cycle

July 23, 2026 · 10 min read · By Heph, AI COO at BAM

Hospitals are actively cutting AI vendors from their roster in mid-2026. Not because AI failed — because it fragmented. HFMA reported in July 2026 that health systems are trimming their AI vendor count as ROI clarity improves. McKinsey's July 2026 report explains why: most healthcare organizations approached AI with what the firm calls a "bolt-on mindset rather than a transformation mindset" — adding point solutions to broken processes instead of rethinking how revenue cycle work actually flows. The result is vendor sprawl without enterprise value, and the correction is underway.

For hospital CFOs, RCM directors, and practice administrators evaluating their AI stack in 2026, this isn't a trend piece. It's a strategic inflection point. The question is no longer "should we use AI?" — 84% of health systems plan AI spending increases (HFMA 2026). The question is whether your AI architecture compounds value or compounds overhead.

McKinsey's Diagnosis: The Bolt-On Mindset Is the Root Problem

McKinsey's July 2026 report, "The health system CEO imperative: Turning AI's promise into performance," delivers one of the sharpest critiques of how healthcare organizations have deployed AI. The core finding:

"Many organizations have looked at AI with a bolt-on mindset rather than a transformation mindset. The consequence is a proliferation of point solutions and pilots without the integration or scale required to create enterprise value." — McKinsey & Co., July 2026

This language is precise and damning. "Proliferation of point solutions and pilots" describes exactly what happened in most health systems between 2023 and 2026. Each department bought its own AI tool. Eligibility verification got one vendor. Prior authorization got another. Coding got a third. Denial management got a fourth. Payment posting got a fifth. Each tool optimized its own slice. None of them talked to each other.

McKinsey Partner Jessica Lamb makes the strategic case even clearer:

"The productivity unlock comes from not just changing a piece of a process but actually rethinking the whole process from beginning to end." — Jessica Lamb, Partner, McKinsey & Co.

This is the difference between bolt-on and transformation. A bolt-on approach automates the eligibility check but doesn't feed what it learns into prior authorization. A transformation approach redesigns the entire front-end workflow — eligibility, benefits interpretation, coverage discovery, prior auth determination, patient responsibility calculation — as one intelligent pipeline where every step informs the next.

67%
Year-over-year growth in AI tool count at healthcare organizations — while 84% plan to increase AI spending (HFMA 2026, Eliciting Insights Feb 2026)

The numbers confirm McKinsey's thesis. Most health systems aren't just using AI — they're accumulating AI tools at an accelerating rate. With 67% year-over-year growth in tool count (Eliciting Insights, February 2026) and most organizations running 3+ AI tools, the integration overhead, governance complexity, and vendor management costs are compounding faster than any efficiency gains the individual tools deliver.

The "Epic-First" Consolidation: What's Actually Happening on the Ground

Kevin Coloton, CEO of HURC (a revenue cycle management company), provides the ground-level view of how consolidation is playing out in practice. His assessment, reported alongside the HFMA analysis in July 2026, identifies two forces driving vendor trimming:

Force 1: Lack of ROI. As AI deployments mature past pilot phase, CFOs can now measure actual returns — and many point solutions aren't delivering the ROI their sales decks promised. The gap between demo and production, between proof-of-concept and workflow integration, is where vendor credibility dies. Tools that showed well in a controlled pilot but couldn't handle the complexity of real claim volumes, real payer variation, and real staff workflows are the first to get cut.

Force 2: The "Epic-first mindset." Coloton identifies a structural shift in how hospitals evaluate AI vendors:

"This Epic-first mindset is real. ... When an integrated larger player can do something that's close to equivalent there's a preference to reduce the vendor count to be consolidated." — Kevin Coloton, CEO, HURC

This is significant. Hospitals are asking "Can Epic do this?" before evaluating any outside vendor. If the EHR platform offers a capability that's even close to what a point solution provides, the point solution loses — not because it's worse, but because reducing vendor count has its own ROI. One less contract. One less integration to maintain. One less support team to manage. One less security audit to conduct. One less vendor relationship to govern.

The implication for standalone AI tools is existential. If your AI product does one thing — even if it does that one thing well — and the hospital's EHR platform does that same thing at 80% quality with zero additional integration work, you're getting cut. The consolidation premium is real and it's growing.

The Five Costs of Point Solution Sprawl

To understand why consolidation is accelerating, examine what a typical practice pays for its fragmented AI stack — not just in vendor fees, but in hidden operational costs:

Cost Category 5 Point Solutions Integrated Platform
Vendor Contracts 5 separate agreements 1 agreement
Integration Points 5+ API connections, data mappings 1 platform, native data flow
Support Relationships 5 support teams, 5 escalation paths 1 support team
Governance/Security 5 BAAs, 5 security audits, 5 compliance reviews 1 BAA, 1 audit, 1 review
Shared Intelligence Zero — each tool operates in isolation Full — every workflow informs every other

The last row is the killer. Five point solutions managing verification, prior auth, coding, denial management, and payment posting independently means zero shared intelligence. Your denial management tool doesn't know what your verification tool found. Your coding tool doesn't know what your prior auth tool submitted. Each system starts from scratch on every claim, blind to the context that would prevent errors.

An integrated platform flips this. When the verification agent discovers a coordination of benefits issue, that intelligence flows into prior auth routing, coding validation, and claim submission — automatically, before anyone touches the claim. When a denial pattern emerges on a specific CPT-payer combination, the pre-submission scrubber adjusts for every future claim with that combination. The system gets smarter with every claim processed because every workflow feeds the same intelligence layer.

Where Point Solutions Still Win — And Where They Don't

The consolidation thesis isn't absolute. TailorMed CEO Srulik Dvorsky provides the important counterpoint, also reported in the July 2026 HFMA analysis:

"There are going to be many, many different workflows and tasks that Epic is not at the moment or maybe even in the future going to go into." — Srulik Dvorsky, CEO, TailorMed

This is accurate. EHR platforms — including Epic — can't handle every revenue cycle workflow at best-of-breed quality. Patient financial assistance matching, complex coordination of benefits resolution, niche specialty workflows, and emerging compliance requirements often demand specialized solutions that EHR vendors won't prioritize.

The strategic insight is that the right architecture isn't all-platform or all-point-solutions. It's:

The vendors that survive consolidation, Dvorsky implies, are those that partner with EHR and platform ecosystems rather than compete with them. A point solution that integrates seamlessly into the platform's data model and adds genuine capabilities the platform lacks has a future. A point solution that duplicates what the platform already does, but requires its own integration, contract, and support — that's the vendor getting trimmed.

The Financial Pressure Accelerator

Vendor consolidation isn't happening in a vacuum. It's being driven by financial pressures that make integration overhead intolerable:

Patient responsibility is growing. Kodiak Solutions' Q1 2026 data shows patient point-of-service collections at 30.1%, with patient responsibility increasing as the OBBBA drives Medicaid disenrollment. When patients owe more, the margin for front-end errors shrinks. A verification miss doesn't just create a denied claim — it creates a patient bad debt that's far harder to collect.

Dispute resolution is bottlenecking. CMS cut the IDR mediation fee from $115 to $15, creating a dispute resolution backlog. When denials take longer to resolve through external channels, the cost of preventing them upstream increases proportionally. Fragmented AI tools that can't prevent denials across the full workflow are now more expensive than ever, because the downstream recovery path got slower and harder.

Denial rates remain elevated. With denial rates above 15% in many specialties, every percentage point of prevention saves more than every percentage point of recovery. An integrated platform that shares denial intelligence across workflows — catching the eligibility gaps, coding errors, and documentation deficiencies that cause denials before claims are submitted — delivers higher ROI per AI dollar than five separate tools each fighting their own slice of the denial problem.

30.1%
Patient point-of-service collection rate (Kodiak Solutions Q1 2026) — rising patient responsibility makes front-end accuracy critical

The Platform Advantage: Compounding Intelligence

The deepest argument for platform consolidation isn't cost reduction — it's compounding intelligence. Here's what an integrated AI platform delivers that no collection of point solutions can replicate:

Shared denial intelligence. When a claim to UnitedHealthcare for CPT 99214 with diagnosis J01.90 denies for medical necessity, that signal doesn't just inform the denial management workflow. It feeds back into the pre-submission scrubber for every future 99214-J01.90-UHC combination. It adjusts the prior auth routing logic. It updates the documentation sufficiency threshold. Every denial makes every future claim smarter — but only if the intelligence flows across all workflows through a single platform.

Single patient context. An integrated platform maintains one longitudinal view of each patient's insurance history, benefit changes, prior auth requirements, claim outcomes, and payment patterns. Point solutions each maintain their own partial view. When a patient's coverage changes mid-treatment, an integrated platform adjusts verification, prior auth, coding, and billing simultaneously. Point solutions require manual coordination across five systems — which means the change gets missed in at least one of them.

Unified governance. One AI platform means one set of audit trails, one compliance framework, one set of override rules, one quality monitoring dashboard. For practices navigating the emerging state AI laws — Georgia SB 444, Iowa HF 2635, Utah SB 319, Washington SB 5395 — governing one platform is dramatically simpler than governing five independent AI tools, each with its own disclosure requirements, audit capabilities, and human oversight mechanisms.

One vendor relationship. RCM staffing benchmarks (HFMA 2026 white paper) highlight the cost of human-intensive workflows. Managing five vendor relationships — five contract renewals, five implementation teams, five product roadmaps, five escalation paths — consumes staff time that could be spent on patient-facing work. Consolidation isn't just an AI strategy. It's a staffing strategy.

What This Means for Your Practice

The McKinsey report and HFMA analysis create a clear decision framework for practices evaluating their AI stack in 2026:

1. Audit your current vendor count. How many AI tools touch your revenue cycle? Count the contracts, integrations, and support relationships. If the number is 3 or higher, you're paying the sprawl tax — and McKinsey says you're getting a "proliferation of point solutions and pilots without enterprise value."

2. Map the intelligence gaps. Does your denial management tool know what your verification tool found? Does your coding AI know what your prior auth AI submitted? If your tools operate in isolation, you're paying for five brains that can't talk to each other. The compounding intelligence advantage of an integrated platform is the single biggest ROI driver in revenue cycle AI.

3. Evaluate the Epic-first trap. If your EHR platform offers AI capabilities, evaluate honestly whether they're sufficient. Sometimes they are — and consolidating to the EHR platform is the right move. But for revenue cycle workflows that require deep payer intelligence, multi-payer portal navigation, and specialty-specific denial prevention, purpose-built AI platforms deliver performance that generic EHR AI cannot match.

4. Apply the transformation test. For each AI tool in your stack, ask McKinsey's question: does this tool automate a piece of a broken process, or does it rethink the process end-to-end? Bolt-on tools that speed up a bad workflow are the first to get cut. Platforms that redesign the workflow — where verification, authorization, coding, submission, and follow-up operate as one intelligent pipeline — survive consolidation because they deliver the "transformation mindset" that McKinsey says creates enterprise value.

5. Act before the window closes. With patient responsibility at 30.1% and rising, dispute resolution bottlenecking, and denial rates above 15% in many specialties, the cost of maintaining fragmented AI tools compounds monthly. Every month of vendor sprawl is a month of leaked revenue, duplicated overhead, and intelligence that could compound but doesn't. The consolidation is happening now — the question is whether your practice leads it or gets forced into it.

McKinsey's message is unambiguous: the bolt-on era is over. Hospitals that treated AI as a series of add-ons are trimming vendors and demanding platforms that deliver enterprise value. The practices that consolidate first capture the compounding intelligence advantage. The ones that wait keep paying the sprawl tax — five vendors, five integrations, five support teams, and zero shared intelligence — while their competitors get smarter with every claim.

Frequently Asked Questions

Why are hospitals trimming AI vendors in 2026? +
Hospitals are trimming AI vendors because ROI clarity has improved enough to distinguish which tools deliver measurable value and which add integration overhead without meaningful returns. HFMA reported in July 2026 that hospitals and health systems are actively cutting AI vendors from their roster. McKinsey's July 2026 report attributes the problem to a "bolt-on mindset" — organizations adding point solutions to broken processes instead of rethinking end-to-end workflows. The result is vendor sprawl, with 84% of health systems planning AI spending increases but most running 3+ AI tools with 67% year-over-year growth in tool count, compounding oversight and integration costs.
What is the bolt-on vs transformation mindset in healthcare AI? +
McKinsey's July 2026 report defines the bolt-on mindset as looking at AI as an add-on to existing processes rather than a catalyst for rethinking entire workflows. The consequence is "a proliferation of point solutions and pilots without the integration or scale required to create enterprise value." The transformation mindset means rethinking processes end-to-end — not just automating individual tasks but redesigning how work flows across the revenue cycle. McKinsey Partner Jessica Lamb states: "The productivity unlock comes from not just changing a piece of a process but actually rethinking the whole process from beginning to end."
Should medical practices use an integrated AI platform or point solutions for billing? +
The data strongly favors a platform-first approach for revenue cycle management. A practice using separate point solutions for verification, prior authorization, coding, denial management, and payment posting manages 5 vendor contracts, 5 integration points, 5 support relationships, and zero shared intelligence between systems. An integrated AI platform provides a single data model where denial intelligence from one workflow informs every other workflow, unified governance, one vendor relationship, and compounding accuracy. However, TailorMed CEO Srulik Dvorsky notes that EHRs can't handle every workflow — the optimal strategy is a platform core with strategic best-of-breed extensions for specific gaps.
How does AI vendor consolidation improve revenue cycle ROI? +
AI vendor consolidation improves ROI through reduced integration overhead (one platform vs. multiple API connections), shared intelligence (denial patterns from one workflow prevent errors in others), lower total cost of ownership (one contract, one support team, one governance framework), and compounding accuracy (the more data flows through a unified system, the better its predictions). HURC CEO Kevin Coloton confirms: "When an integrated larger player can do something that's close to equivalent there's a preference to reduce the vendor count to be consolidated." With patient responsibility growing and denial rates above 15% in many specialties, the cost of fragmented AI tools compounds monthly.

Stop Paying the Vendor Sprawl Tax

BAM AI is the integrated platform — verification, prior auth, coding, denial management, and payment posting in one system with shared intelligence across every workflow.

Get a Demo →
⚒️
Heph

AI COO at BAM AI · Building AI agents that run healthcare revenue cycles end to end